These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 7706536)
1. Tetracyclines in the management of periodontal diseases. A review. Seymour RA; Heasman PA J Clin Periodontol; 1995 Jan; 22(1):22-35. PubMed ID: 7706536 [TBL] [Abstract][Full Text] [Related]
2. Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fluid in different periodontal diseases. A review article. Ingman T; Sorsa T; Suomalainen K; Halinen S; Lindy O; Lauhio A; Saari H; Konttinen YT; Golub LM J Periodontol; 1993 Feb; 64(2):82-8. PubMed ID: 8433257 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological control of periodontal disease. II. Antimicrobial agents. Seymour RA; Heasman PA J Dent; 1995 Feb; 23(1):5-14. PubMed ID: 7876417 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of bacterial resistance to tetracyclines in the treatment of periodontal diseases. Greenstein G J Periodontol; 1995 Nov; 66(11):925-32. PubMed ID: 8558393 [TBL] [Abstract][Full Text] [Related]
5. The nonantimicrobial properties of tetracycline for the treatment of periodontal disease. Vernillo AT; Ramamurthy NS; Golub LM; Rifkin BR Curr Opin Periodontol; 1994; ():111-8. PubMed ID: 8032451 [TBL] [Abstract][Full Text] [Related]
6. Current status of systemic antibiotic usage in destructive periodontal disease. Gordon JM; Walker CB J Periodontol; 1993 Aug; 64(8 Suppl):760-71. PubMed ID: 8410616 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines. Ramamurthy NS; Rifkin BR; Greenwald RA; Xu JW; Liu Y; Turner G; Golub LM; Vernillo AT J Periodontol; 2002 Jul; 73(7):726-34. PubMed ID: 12146531 [TBL] [Abstract][Full Text] [Related]
8. Pharmacologic management of periodontal diseases using systemically administered agents. Mariotti A; Monroe PJ Dent Clin North Am; 1998 Apr; 42(2):245-62. PubMed ID: 9597336 [TBL] [Abstract][Full Text] [Related]
9. Treating periodontal diseases with tetracycline-impregnated fibers: data and controversies. Greenstein G Compend Contin Educ Dent; 1995 May; 16(5):448-55; quiz 456. PubMed ID: 8624985 [TBL] [Abstract][Full Text] [Related]
10. Tetracycline and its analogues: a therapeutic paradigm in periodontal diseases. Weinberg MA; Bral M Crit Rev Oral Biol Med; 1998; 9(3):322-32. PubMed ID: 9715369 [TBL] [Abstract][Full Text] [Related]
12. Host modulation with tetracyclines and their chemically modified analogues. Golub LM; Suomalainen K; Sorsa T Curr Opin Dent; 1992 Mar; 2():80-90. PubMed ID: 1325849 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial agents in the prevention and treatment of periodontal diseases. Bral M; Brownstein CN Dent Clin North Am; 1988 Apr; 32(2):217-41. PubMed ID: 3288511 [TBL] [Abstract][Full Text] [Related]
14. Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline. Slots J; Rosling BG J Clin Periodontol; 1983 Sep; 10(5):465-86. PubMed ID: 6579058 [TBL] [Abstract][Full Text] [Related]
15. Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD). Caton J; Ryan ME Pharmacol Res; 2011 Feb; 63(2):114-20. PubMed ID: 21182947 [TBL] [Abstract][Full Text] [Related]
16. [Clinical use of tetracyclines in the treatment of periodontal diseases]. Bokor-Bratić M; Brkanić T Med Pregl; 2000; 53(5-6):266-71. PubMed ID: 11089368 [TBL] [Abstract][Full Text] [Related]
17. Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases. Golub LM; Elburki MS; Walker C; Ryan M; Sorsa T; Tenenbaum H; Goldberg M; Wolff M; Gu Y Int Dent J; 2016 Jun; 66(3):127-35. PubMed ID: 27009489 [TBL] [Abstract][Full Text] [Related]